For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on July 17th, 2025 | 07:00 CEST
300% share Almonty Industries: What is next? Strategic partnerships like MP Materials?
Following its NASDAQ listing on Monday, things have quieted down somewhat for high-flyer Almonty Industries - a healthy pause after a year-to-date rally of over 300%. This may even present a buying opportunity or a chance to increase positions. The tungsten gem is likely to generate significant positive news flow in the coming months, including the production start at its tungsten mine in South Korea, new analyst coverage, and possibly even a strategic partnership, similar to what MP Materials achieved. The latter recently made headlines with a US government investment and a partnership with Apple. Although tungsten is not classified as a rare earth element, it can be considered just as critical for defense and high-tech applications.
Read
Commented by Fabian Lorenz on July 16th, 2025 | 07:25 CEST
WINNING STOCKS for the second half of the year!? Rheinmetall, Bayer, and Hotstock PanGenomic Health
Hard to believe: Bayer shares are among the winners in 2025. And even the news flow is positive. Does the Leverkusen-based company even have a new blockbuster in the pipeline? What do analysts say? PanGenomic Health shares could be among the stars of the second half of the year. With a new health app, the Company is entering a billion-dollar market in the US and benefiting from the Trump administration. If it succeeds in securing market share, the stock should have plenty of upside potential. Analysts believe that the air is getting thinner for Rheinmetall shares. However, it is likely only a matter of time before the EUR 2,000 mark is broken.
Read
Commented by Fabian Lorenz on July 15th, 2025 | 07:00 CEST
Attention! MULTIPLICATION potential! Hensoldt, D-Wave, and naoo shares with Buy recommendations
German defense stocks appear to have quickly ended their consolidation phase. Driven by Buy recommendations, they are marching back toward their all-time highs. Hensoldt is recommended by Deutsche Bank, among others. However, the Company could face significant challenges ahead! Meanwhile, there is a bombshell from naoo: for the first time, analysts have taken a closer look at the Swiss social media insider tip. Experts see strong growth in the coming years and believe a multiplication of the stock price is possible. D-Wave's share price has already multiplied. Nevertheless, analysts see further upside potential for the quantum high-flyer.
Read
Commented by Fabian Lorenz on July 14th, 2025 | 07:10 CEST
Siemens Energy gifted away? RENK is betting on AI! First Hydrogen shares rally 100%!
The opportunities of hydrogen and nuclear power in one stock? First Hydrogen offers just that. Over the past 4 months, the stock has more than doubled. Nevertheless, it still does not appear to be expensive, as the global hunger for energy and thus the potential for First Hydrogen is huge. This energy demand is also driven by the AI hype, which is causing data centers to spring up like mushrooms. RENK is turning to artificial intelligence for the future. The Company may focus even more on defense going forward. Analysts view this positively. Siemens Energy shares have increased more than tenfold in recent years. But is the core business still being offered for free? A look at India suggests this might be the case. A buying opportunity?
Read
Commented by Fabian Lorenz on July 11th, 2025 | 07:20 CEST
Biotech takeover merry-go-round picks up speed! BioNTech, Evotec, Merck, and BioNxt Solutions!
The takeover merry-go-round is spinning faster again in the biotech sector. The latest example is Merck's acquisition of Verona Pharma. The US group is paying USD 10 billion for the deal. BioNxt Solutions would be significantly cheaper to acquire at present. The Company aims to make it easier to take medication with melt films, skin patches, and tablets. In addition, it has now announced an exciting platform. The goal is to develop smarter chemotherapy, which, in turn, could create a billion-dollar market. And what are BioNTech and Evotec doing? Things have quieted down a bit at the German biotech leader following its billion-dollar deal with Bristol-Myers Squibb. However, analysts recommend buying the stock. Evotec, on the other hand, is languishing at around EUR 7. Can the quarterly figures provide new impetus for the struggling stock?
Read
Commented by Fabian Lorenz on July 11th, 2025 | 07:10 CEST
More than 100% price gain! Volkswagen, Standard Lithium, and BMW partner European Lithium! Comeback for EVs and lithium!
Lithium shares are staging a comeback - without much attention. Standard Lithium's share price has already more than doubled in the current year. The US-based company is delivering strong news. European Lithium has also performed well recently. And for good reason: not only is the Company developing a large project in Europe, but it also has access to rare earths in Greenland. Will this soon make it a partner of the EU in building up a strategic reserve? After all, Volkswagen, BMW, and Mercedes need more and more batteries. While BYD and Tesla are currently struggling, German manufacturers are celebrating a comeback in the electric vehicle market, at least in Europe.
Read
Commented by Fabian Lorenz on July 10th, 2025 | 07:20 CEST
Hydrogen Stocks: Are Nel and Plug Power on the way out? Is it better to bet on thyssenkrupp nucera and Pure Hydrogen?
Australia has a good chance of playing a key role in the future hydrogen market – particularly when it comes to green hydrogen from renewable sources. CSIRO and Deloitte see billions in potential. Pure Hydrogen aims to profit from this. The Australians are currently building a hydrogen ecosystem and have celebrated initial sales successes and are already concluding global partnerships. The stock is anything but expensive and remains an insider tip. Nel, on the other hand, is floundering this year. The euphoria surrounding Samsung's entry has fizzled out. Will there be new impetus next week? Perhaps new funding? Meanwhile, thyssenkrupp nucera is making bold moves. On the one hand, the Company has secured technology from the insolvent Danish company Green Hydrogen Systems and secured a million-dollar contract from Saudi Arabia.
Read
Commented by Fabian Lorenz on July 9th, 2025 | 07:10 CEST
Almonty Industries: The NASDAQ countdown is on! Everyone wants a piece of the Tungsten Gem!
The countdown to Almonty's IPO on the NASDAQ is underway. The reverse split took place on Friday, and further details were released yesterday. A capital increase of around 10% is being supported by renowned banks. The fresh capital is intended to be used to extend the value chain. This move should enable Almonty to consolidate its position as the most important tungsten supplier in the West. The share price is responding with a spectacular rise. In addition, Europe appears to be slowly awakening to the issue of critical raw materials. Almonty stands to benefit from this as well. The outlook for this tungsten gem remains bright. The share price performance is more than just FOMO; it is based on geopolitical and operational fundamentals.
Read
Commented by Fabian Lorenz on July 9th, 2025 | 07:00 CEST
Plug Power, TUI, and Argo Graphene Solutions: Who is revolutionizing?
The construction revolution has a new name: Argo Graphene Solutions. With this name, the Company is also formally completing its repositioning. Operationally, it is already working on a revolution: revolutionizing concrete and asphalt by adding graphene. To this end, it has now opened its first commercial site in the US. If the rollout is successful, the stock has the potential to multiply in value. Only the most optimistic investors still believe in Plug Power. The former hydrogen darling has disappointed investors too often. In recent weeks, the stock has risen by over 30%. What is behind this? TUI has underperformed the DAX in the current year. Yet operations are running smoothly. In the cruise sector, capacity has been significantly increased, and the Company has exceeded its own booking targets. But it is not all good news.
Read
Commented by Fabian Lorenz on July 8th, 2025 | 07:05 CEST
Rheinmetall above EUR 2,000? Bayer shares exhausted? NetraMark Holdings with lots of upside potential!
It seems only a matter of time before Rheinmetall shares break through the EUR 2,000 barrier. Increasingly, analysts are setting price targets above this mark. And operations are running smoothly, as demonstrated by the latest ammunition order and the Company's participation in the German government's billion-euro investment program. NetraMark, on the other hand, does not have to invest billions in research and development. The AI specialist is still an insider tip. However, the first study is now available, and analysts anticipate over 50% upside potential. In contrast, analysts see the end of the price fireworks at Bayer. Are they right?
Read